1. Home
  2. HLP vs ADAG Comparison

HLP vs ADAG Comparison

Compare HLP & ADAG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Hongli Group Inc.

HLP

Hongli Group Inc.

SELL

Current Price

$3.42

Market Cap

224.2M

Sector

Industrials

ML Signal

SELL

Logo Adagene Inc.

ADAG

Adagene Inc.

HOLD

Current Price

$1.43

Market Cap

222.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HLP
ADAG
Founded
2021
2011
Country
China
China
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
224.2M
222.2M
IPO Year
2021
2020

Fundamental Metrics

Financial Performance
Metric
HLP
ADAG
Price
$3.42
$1.43
Analyst Decision
Strong Buy
Analyst Count
0
6
Target Price
N/A
★ $9.91
AVG Volume (30 Days)
★ 406.8K
300.8K
Earning Date
12-01-2026
08-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$129.59
P/E Ratio
$51.63
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.34
$1.27
52 Week High
$4.90
$4.85

Technical Indicators

Market Signals
Indicator
HLP
ADAG
Relative Strength Index (RSI) 49.61 26.33
Support Level $0.77 N/A
Resistance Level $4.69 $4.16
Average True Range (ATR) 0.64 0.30
MACD -0.07 -0.06
Stochastic Oscillator 35.27 1.89

Price Performance

Historical Comparison
HLP
ADAG

About HLP Hongli Group Inc.

Hongli Group Inc is an offshore holding company. Through its subsidiaries, it is engaged in the cold-rolled steel profile manufacturing in China. Its main business operation focuses on the design, production, deep processing, and sales of custom-made profiles for machinery and equipment in a variety of sectors, including but not limited to mining and excavation, construction, agriculture, and transportation industries. The group operates in a single segment, which manufactures and sells agricultural machinery cab assemblies, construction machinery cab assemblies, excavator cab assemblies, and special-shaped steel pipes. It generates the majority of its reveneue from PRC.

About ADAG Adagene Inc.

Adagene Inc is a platform-driven, clinical-stage biotechnology company focused on the discovery and development of novel antibody-based cancer immunotherapies. The Company leverages computational biology to design and develop novel antibodies. Powered by its Dynamic Precision Library (DPL) platform, which fuels its NEObody, SAFEbody, and POWERbody technologies, it is developing a pipeline of immunotherapies. Its candidate, ADG126 (muzastotug), an anti-CTLA-4 SAFEbody, is in phase 1b/2 and phase 2 clinical development for metastatic microsatellite-stable colorectal cancer. Its clinical-stage products include ADG126 and ADG116, investigational fully human anti-CTLA-4 mAbs generated through SAFEbody and NEObody technologies.

Share on Social Networks: